137 related articles for article (PubMed ID: 29163771)
1. Inhibition of HOX/PBX dimer formation leads to necroptosis in acute myeloid leukemia cells.
Alharbi RA; Pandha HS; Simpson GR; Pettengell R; Poterlowicz K; Thompson A; Harrington K; El-Tanani M; Morgan R
Oncotarget; 2017 Oct; 8(52):89566-89579. PubMed ID: 29163771
[TBL] [Abstract][Full Text] [Related]
2. Targeting HOX/PBX dimer formation as a potential therapeutic option in esophageal squamous cell carcinoma.
Shen LY; Zhou T; Du YB; Shi Q; Chen KN
Cancer Sci; 2019 May; 110(5):1735-1745. PubMed ID: 30844117
[TBL] [Abstract][Full Text] [Related]
3. Targeting HOX-PBX interactions causes death in oral potentially malignant and squamous carcinoma cells but not normal oral keratinocytes.
Platais C; Radhakrishnan R; Niklander Ebensperger S; Morgan R; Lambert DW; Hunter KD
BMC Cancer; 2018 Jul; 18(1):723. PubMed ID: 29980182
[TBL] [Abstract][Full Text] [Related]
4. Targeting the HOX/PBX dimer in breast cancer.
Morgan R; Boxall A; Harrington KJ; Simpson GR; Gillett C; Michael A; Pandha HS
Breast Cancer Res Treat; 2012 Nov; 136(2):389-98. PubMed ID: 23053648
[TBL] [Abstract][Full Text] [Related]
5. HOX transcription factors are potential targets and markers in malignant mesothelioma.
Morgan R; Simpson G; Gray S; Gillett C; Tabi Z; Spicer J; Harrington KJ; Pandha HS
BMC Cancer; 2016 Feb; 16():85. PubMed ID: 26867567
[TBL] [Abstract][Full Text] [Related]
6. Targeting HOX/PBX dimers in cancer.
Morgan R; El-Tanani M; Hunter KD; Harrington KJ; Pandha HS
Oncotarget; 2017 May; 8(19):32322-32331. PubMed ID: 28423659
[TBL] [Abstract][Full Text] [Related]
7. An inhibitory switch derepressed by pbx, hox, and Meis/Prep1 partners regulates DNA-binding by pbx1 and E2a-pbx1 and is dispensable for myeloid immortalization by E2a-pbx1.
Calvo KR; Knoepfler P; McGrath S; Kamps MP
Oncogene; 1999 Dec; 18(56):8033-43. PubMed ID: 10637514
[TBL] [Abstract][Full Text] [Related]
8. Disrupting the interaction between HOX and PBX causes necrotic and apoptotic cell death in the renal cancer lines CaKi-2 and 769-P.
Shears L; Plowright L; Harrington K; Pandha HS; Morgan R
J Urol; 2008 Nov; 180(5):2196-201. PubMed ID: 18804814
[TBL] [Abstract][Full Text] [Related]
9. Targeting HOX and PBX transcription factors in ovarian cancer.
Morgan R; Plowright L; Harrington KJ; Michael A; Pandha HS
BMC Cancer; 2010 Mar; 10():89. PubMed ID: 20219106
[TBL] [Abstract][Full Text] [Related]
10. HoxB8 requires its Pbx-interaction motif to block differentiation of primary myeloid progenitors and of most cell line models of myeloid differentiation.
Knoepfler PS; Sykes DB; Pasillas M; Kamps MP
Oncogene; 2001 Sep; 20(39):5440-8. PubMed ID: 11571641
[TBL] [Abstract][Full Text] [Related]
11. The prognostic significance of specific HOX gene expression patterns in ovarian cancer.
Kelly Z; Moller-Levet C; McGrath S; Butler-Manuel S; Kavitha Madhuri T; Kierzek AM; Pandha H; Morgan R; Michael A
Int J Cancer; 2016 Oct; 139(7):1608-17. PubMed ID: 27225067
[TBL] [Abstract][Full Text] [Related]
12. Targeting HOX transcription factors in prostate cancer.
Morgan R; Boxall A; Harrington KJ; Simpson GR; Michael A; Pandha HS
BMC Urol; 2014 Feb; 14():17. PubMed ID: 24499138
[TBL] [Abstract][Full Text] [Related]
13. [Identification of proteins associated with transcription factors HOXA9 and E2A-PBX1 by tandem affinity purification].
Shestakova EA; Boutin M; Bourassa S; Bonneil E; Bijl JJ
Mol Biol (Mosk); 2017; 51(3):490-501. PubMed ID: 28707666
[TBL] [Abstract][Full Text] [Related]
14. Defining roles for HOX and MEIS1 genes in induction of acute myeloid leukemia.
Thorsteinsdottir U; Kroon E; Jerome L; Blasi F; Sauvageau G
Mol Cell Biol; 2001 Jan; 21(1):224-34. PubMed ID: 11113197
[TBL] [Abstract][Full Text] [Related]
15. Peptide-based inhibition of the HOXA9/PBX interaction retards the growth of human meningioma.
Ando H; Natsume A; Senga T; Watanabe R; Ito I; Ohno M; Iwami K; Ohka F; Motomura K; Kinjo S; Ito M; Saito K; Morgan R; Wakabayashi T
Cancer Chemother Pharmacol; 2014 Jan; 73(1):53-60. PubMed ID: 24141373
[TBL] [Abstract][Full Text] [Related]
16. Smac mimetic primes apoptosis-resistant acute myeloid leukaemia cells for cytarabine-induced cell death by triggering necroptosis.
Chromik J; Safferthal C; Serve H; Fulda S
Cancer Lett; 2014 Mar; 344(1):101-109. PubMed ID: 24184825
[TBL] [Abstract][Full Text] [Related]
17. NUP98-HOXA9 bearing therapy-related myeloid neoplasm involves myeloid-committed cell and induces HOXA5, EVI1, FLT3, and MEIS1 expression.
Burillo-Sanz S; Morales-Camacho RM; Caballero-Velázquez T; Vargas MT; García-Lozano JR; Falantes JF; Prats-Martín C; Bernal R; Pérez-Simón JA
Int J Lab Hematol; 2016 Feb; 38(1):64-71. PubMed ID: 26418229
[TBL] [Abstract][Full Text] [Related]
18. Identification of a novel synergistic induction of cell death by Smac mimetic and HDAC inhibitors in acute myeloid leukemia cells.
Steinwascher S; Nugues AL; Schoeneberger H; Fulda S
Cancer Lett; 2015 Sep; 366(1):32-43. PubMed ID: 26028172
[TBL] [Abstract][Full Text] [Related]
19. Molecular features and vulnerabilities of recurrent chordomas.
Seeling C; Lechel A; Svinarenko M; Möller P; Barth TFE; Mellert K
J Exp Clin Cancer Res; 2021 Jul; 40(1):244. PubMed ID: 34330313
[TBL] [Abstract][Full Text] [Related]
20. The highest affinity DNA element bound by Pbx complexes in t(1;19) leukemic cells fails to mediate cooperative DNA-binding or cooperative transactivation by E2a-Pbx1 and class I Hox proteins - evidence for selective targetting of E2a-Pbx1 to a subset of Pbx-recognition elements.
Knoepfler PS; Kamps MP
Oncogene; 1997 May; 14(21):2521-31. PubMed ID: 9191052
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
